Amrutanjan Health Care share news, announcements and annual reports
NSE: AMRUTANJANBSE: 590006Pharmaceuticals & BiotechnologySmall Cap
Amrutanjan Health Care Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary
Last close ₹493.20up ₹0.20 (0.04%)BSE ₹493.40
Share price at the NSE close on 29 Oct 2026. Previous close ₹493.00.
29 Oct: open ₹490.10, high ₹500.00, low ₹490.10
52-week range of traded prices to 29 Oct 2026
₹476.50Low, 16 Sep 2026₹760.15High, 29 Oct 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,426 Cr1,245th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.42
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 21.99
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.85
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.99%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 18.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 13,00054.0% delivered
Amrutanjan Health Care orders, deals and press releases
11 filed, newest first.
Apr 2026
17 Apr · Business
Oct 2025
14 Oct · Business
Nov 2022
2 Nov · Business
Mar 2019
12 Mar · Business
Aug 2018
Jul 2018
Feb 2018
Jul 2017
Feb 2017
Apr 2011
20 Apr · Business
New business activity as follows:" In order to forward integrate from products to services, the Company has entered into a New Business activity viz. Pain Management. The Board of Directors of the Company has granted approval for the same. The objects clause of the Company was also revised with the approval of the shareholders through postal ballot, for this purpose. In furtherance of the said objects, the Company is shortly to open its first centre for specialized Pain Management in T. Nagar, Chennai, which would provide treatment from non-invasive to invasive interventions. More details on this can be obtained from the Company's website" (Source MSE)
Mar 2011
3 Mar · Business
Company has entered into an agreement with M/s. Siva's Soft Drink Private Limited, Chennai, to acquire their soft drink and fruit based beverages business along with the brand, 'Fruitnik' for a total consideration of Rs. 26.20 Crores. (Source MSE)